CME Group (CME) Receives New Coverage from Analysts at Barclays
Barclays began coverage on shares of CME Group (NASDAQ:CME) in a research report report published on Tuesday, MarketBeat.com reports. The brokerage issued an overweight rating and a $210.00 price target on the financial services provider’s stock.
CME has been the subject of a number of other research reports. Zacks Investment Research upgraded CME Group from a sell rating to a hold rating in a research report on Wednesday, October 3rd. Bank of America restated a buy rating and issued a $200.00 price target on shares of CME Group in a research report on Monday, November 5th. Berenberg Bank upgraded CME Group from a hold rating to a buy rating and set a $220.00 price target for the company in a research report on Tuesday, November 20th. Jefferies Financial Group raised their price target on CME Group to $203.00 and gave the company a buy rating in a research report on Monday, October 8th. Finally, BidaskClub upgraded CME Group from a buy rating to a strong-buy rating in a research report on Tuesday, October 9th. Six equities research analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the company. CME Group presently has an average rating of Buy and a consensus price target of $194.13.
Shares of CME stock opened at $187.11 on Tuesday. CME Group has a fifty-two week low of $143.68 and a fifty-two week high of $197.08. The firm has a market capitalization of $64.24 billion, a PE ratio of 39.23, a PEG ratio of 2.19 and a beta of 0.46. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.09 and a quick ratio of 1.09.
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, December 27th. Investors of record on Monday, December 10th will be given a dividend of $0.70 per share. This represents a $2.80 dividend on an annualized basis and a yield of 1.50%. The ex-dividend date of this dividend is Friday, December 7th. CME Group’s dividend payout ratio is presently 58.70%.
In related news, insider Julie Winkler sold 5,847 shares of CME Group stock in a transaction dated Friday, November 16th. The stock was sold at an average price of $195.01, for a total transaction of $1,140,223.47. Following the completion of the sale, the insider now owns 24,255 shares in the company, valued at approximately $4,729,967.55. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Chairman Terrence A. Duffy sold 10,000 shares of CME Group stock in a transaction dated Friday, November 23rd. The stock was sold at an average price of $188.80, for a total value of $1,888,000.00. Following the sale, the chairman now owns 95,652 shares of the company’s stock, valued at approximately $18,059,097.60. The disclosure for this sale can be found here. In the last quarter, insiders have sold 29,800 shares of company stock valued at $5,628,462. 0.43% of the stock is currently owned by company insiders.
A number of institutional investors have recently bought and sold shares of CME. Capital Research Global Investors increased its position in CME Group by 107.8% during the 3rd quarter. Capital Research Global Investors now owns 10,906,683 shares of the financial services provider’s stock worth $1,856,427,000 after purchasing an additional 5,658,108 shares in the last quarter. Capital International Investors increased its position in CME Group by 18.3% during the 3rd quarter. Capital International Investors now owns 15,425,378 shares of the financial services provider’s stock worth $2,625,554,000 after purchasing an additional 2,383,280 shares in the last quarter. AustralianSuper Pty Ltd purchased a new stake in CME Group during the 3rd quarter worth about $172,308,000. Edgewood Management LLC increased its position in CME Group by 9.5% during the 3rd quarter. Edgewood Management LLC now owns 8,582,518 shares of the financial services provider’s stock worth $1,460,830,000 after purchasing an additional 742,067 shares in the last quarter. Finally, Janus Henderson Group PLC increased its position in CME Group by 13.2% during the 2nd quarter. Janus Henderson Group PLC now owns 6,129,157 shares of the financial services provider’s stock worth $1,004,691,000 after purchasing an additional 716,655 shares in the last quarter. Hedge funds and other institutional investors own 85.89% of the company’s stock.
CME Group Company Profile
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.
See Also: Reverse Stock Split
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.